These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11187883

  • 21. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S, Ghods R, Bahrami ZS, Roohi A, Jeddi-Tehrani M, Conti-Fine BM, Sharifian RA, Rabbani H, Shokri F.
    Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
    [Abstract] [Full Text] [Related]

  • 22. Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies.
    Kessel C, Kreuz W, Klich K, Becker-Peters K, Vorpahl F, Dietrich U, Klingebiel T, Königs C.
    ChemMedChem; 2009 Aug; 4(8):1364-70. PubMed ID: 19533722
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
    Blanco AN, Peirano AA, Grosso SH, Gennari LC, Bianco RP, Lazzari MA.
    Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
    Mariani G, Kroner B, Immune Tolerance Study Group (ITSG).
    Haematologica; 2001 Nov; 86(11):1186-93. PubMed ID: 11694405
    [Abstract] [Full Text] [Related]

  • 27. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y, Shima M, Tanaka I, Fukuda K, Yoshida K, Yoshioka A.
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.
    J Immunol Methods; 2006 Jan 20; 308(1-2):90-100. PubMed ID: 16376372
    [Abstract] [Full Text] [Related]

  • 30. Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
    Huguet HC, Lasne D, Rothschild C, Siali R, Jozefonvicz J.
    Thromb Haemost; 2004 Feb 20; 91(2):259-66. PubMed ID: 14961152
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
    Behrmann M, Pasi J, Saint-Remy JM, Kotitschke R, Kloft M.
    Thromb Haemost; 2002 Aug 20; 88(2):221-9. PubMed ID: 12195693
    [Abstract] [Full Text] [Related]

  • 33. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
    Wang W, Merchlinsky M, Inman J, Golding B.
    Thromb Res; 2005 Aug 20; 116(4):335-44. PubMed ID: 16038719
    [Abstract] [Full Text] [Related]

  • 34. Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
    Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.
    Thromb Haemost; 2005 Nov 20; 94(5):933-41. PubMed ID: 16363233
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S, Sooryanarayana, Moreau A, Horn MP, Kazatchkine MD, Kaveri SV.
    Chem Immunol; 2000 Nov 20; 77():102-14. PubMed ID: 11706701
    [No Abstract] [Full Text] [Related]

  • 39. Kinetics of factor VIII:C inhibitors and treatment response in severe hemophilia A patients.
    Luna-Záizar H, Esparza-Flores MA, López-Guido B, Aguilar-López LB, Cortés Alvarez CR, Jaloma-Cruz AR.
    Int J Lab Hematol; 2009 Dec 20; 31(6):673-82. PubMed ID: 18771497
    [Abstract] [Full Text] [Related]

  • 40. F VIII subunits: purification and antigenic properties.
    Nordfang O, Ezban M, Hansen JJ.
    Thromb Haemost; 1987 Dec 18; 58(4):1043-8. PubMed ID: 3127917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.